Penicillin derivatives inhibit the SARS-CoV-2 main protease by reaction with its nucleophilic cysteine

TR Malla, L Brewitz, DG Muntean… - Journal of medicinal …, 2022 - ACS Publications
The SARS-CoV-2 main protease (Mpro) is a medicinal chemistry target for COVID-19
treatment. Given the clinical efficacy of β-lactams as inhibitors of bacterial nucleophilic …
被引用次数：27 相关文章
[HTML] nih.gov

[HTML][HTML] Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine

TR Malla, L Brewitz, DG Muntean, H Aslam… - Journal of Medicinal …, 2022 - ncbi.nlm.nih.gov
The SARS-CoV-2 main protease (Mpro) is a medicinal chemistry target for COVID-19
treatment. Given the clinical efficacy of β-lactams as inhibitors of bacterial nucleophilic …

Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine.

TR Malla, L Brewitz, DG Muntean, H Aslam… - Journal of Medicinal …, 2022 - europepmc.org
The SARS-CoV-2 main protease (Mpro) is a medicinal chemistry target for COVID-19
treatment. Given the clinical efficacy of β-lactams as inhibitors of bacterial nucleophilic …

Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine

TR Malla, L Brewitz, DG Muntean… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The SARS-CoV-2 main protease (M pro) is a medicinal chemistry target for COVID-19
treatment. Given the clinical efficacy of β-lactams as inhibitors of bacterial nucleophilic …

Penicillin derivatives inhibit the SARS-CoV-2 main protease by reaction with its nucleophilic cysteine

TR Malla, L Brewitz, DG Muntean, H Aslam… - Journal of Medicinal …, 2022 - ora.ox.ac.uk
The SARS-CoV-2 main protease (M pro) is a medicinal chemistry target for COVID-19
treatment. Given the clinical efficacy of β-lactams as inhibitors of bacterial nucleophilic …

Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine

TR Malla, L Brewitz, DG Muntean… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The SARS-CoV-2 main protease (M pro) is a medicinal chemistry target for COVID-19
treatment. Given the clinical efficacy of β-lactams as inhibitors of bacterial nucleophilic …